Centogene supervisory board
WebNov 21, 2024 · CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science … WebNov 13, 2024 · CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 13, 2024 (GLOBE NEWSWIRE) -- CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced …
Centogene supervisory board
Did you know?
WebApr 10, 2024 · -- Centogene N.V said Tuesday it expanded its partnership with Takeda Pharmaceutical Co. to diagnose patients with lysosomal storage disorders, or LSDs. Under the one-year renewed partnership... April 11, 2024 ... Chairman-Supervisory Board: Peter Bauer: Chief Medical & Genomic Officer: Michael Dost: Senior Director-Information … WebNov 21, 2024 · “We are very pleased to welcome Ms. Sheahan as a new member of the Supervisory Board,” stated Peer Schatz, Chairman of the Supervisory Board of …
WebBenefits of Testing with CENTOGENE Our Tests How to Order Multiomic Solutions NGS Panels WES WGS CentoCloud® Pharma What We Do for Pharma Clinical Trial Support … WebNov 21, 2024 · “We are very pleased to welcome Ms. Sheahan as a new member of the Supervisory Board,” stated Peer Schatz, Chairman of the Supervisory Board of …
WebApr 12, 2024 · Centogene N.V. kondigt de lancering aan van NEW CentoGenome, een verbeterde op Next Generation Sequencing gebaseerde assay. Zorgverleners kunnen met behulp van NEW CentoGenome uitgebreidere... 13 april 2024 WebApr 11, 2024 · Centogene N.V. gab bekannt, dass es seine Partnerschaft mit Takeda zur Diagnose von Patienten mit lysosomalen Speicherkrankheiten verlängert hat. Im Rahmen der erneuerten einjährigen... 12 April 2024
WebApr 11, 2024 · By Chris Wack. Centogene N.V. said Tuesday that it has extended its partnership with Takeda Pharmaceutical Co. to diagnose patients with Lysosomal Storage Disorders. Under the renewed one-year partnership agreement, Centogene will continue to provide Takeda with access to diagnostic testing for patients around the world.
thalia fyfeWebFeb 1, 2024 · CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG), a commercial-stage company focused on generating ... synthes dorsale radiusplatteWeb2 days ago · Centogene N.V. announced the launch of NEW CentoGenome, an enhanced Next Generation Sequencing (NGS)-based assay. Healthcare professionals can leverage NEW CentoGenome to provide more comprehensive diagnostic information, which could accelerate access to potential treatment options. synthes drill guideWebNov 21, 2024 · “We are very pleased to welcome Ms. Sheahan as a new member of the Supervisory Board,” stated Peer Schatz, Chairman of the Supervisory Board of CENTOGENE. “Mary has been instrumental in financial management, driving strategic decision-making and delivering value creation for patients and stakeholders over the … synthes distal ulna plateWebJun 23, 2024 · Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced that its Supervisory Board member Christoph Ehlers has resigned from office, effective June 15, 2024. synthese14とsynthese15の違いWebJan 1, 2024 · Effective from January 1, 2024, Peer Schatz has been appointed Chairman of the Supervisory Board of CENTOGENE. Peer is the Managing Director of PS Capital … CENTOGENE is the unique and essential partner for patients, physicians, and … synthes dynamic locking screwWebApr 12, 2024 · Centogene N.V. a annoncé le lancement de NEW CentoGenome, un test amélioré basé sur le séquençage de nouvelle génération . Les professionnels de la santé peuvent utiliser NEW CentoGenome ... thalia frechen